The HPV testing and Pap test market size was valued at USD 1.67 billion in 2020 and is expected to surpass USD 7.25 billion, expanding at a CAGR of 16.4% during the forecast period, 2021–2028. The growth of the market is attributed to the rising number of cervical cancer screening events and development of several innovative screening devices.
Request Free Sample Report Here
HPV testing and Pap test are primarily used for the detection of cancerous cells in the body. HPV or human papillomavirus consists of a group of more than 150 related viruses and Pap tests are widely used to identify tumor formation and precancers in the cervix. Precancers are mainly caused by HPV and some of the HPV types develops cervical cancer without proper treatment.
Market Trends, Drivers, Restraints, and Opportunities
- Rising number of cervical cancer cases worldwide present key factor driving the market growth.
- Increasing governments’ initiatives and policies for public awareness programs especially for women are another major factors for the market expansion.
- High incidence of cervical cancer especially vaginal cancer and increasing demand for innovative screening techniques for the treatment are major factors which are expected to drive the market growth.
- Increasing technology advancement in diagnostic procedures and development of several screening techniques by major players in the market are likely to boost the market.
- The COVID-19 pandemic and its dire consequences have impacted to enormously reduce regular cancer screening tests. This acts as a key restraining factor for the market.
Market Segment Insights
HPV testing segment is expected to grow at a rapid pace
Based on test types, the global HPV testing and Pap test market is bifurcated into HPV testing and Pap test. The HPV testing segment is expected to grow at a rapid pace during the projected period due to rising commercialization of innovative tests related to HPV infection. However, the Pap test segment is anticipated to account for a key share of the market during the forecast period owing to increasing awareness programs by healthcare authorities and rising implementation of policies to adopt mandatory screening of cervical cancer.
Vaginal cancer screening segment is projected to expand at a considerable CAGR
On the basis of applications, the market is bifurcated into cervical cancer screening and vaginal cancer screening. The cervical cancer screening segment is projected to hold a key market share in the coming years owing to higher incidence of cervical cancer and growing public-private initiatives to increase screening of cervical cancer. On the other hand, the vaginal cancer screening segment is anticipated to expand at a considerable CAGR during the forecast period due to high mortality rates of vaginal cancer and demand for screening test.
Consumables segment is expected to expand at a robust growth rate
Based on products, the global HPV testing and Pap test market is divided into instruments, consumables, and services. The services segment is anticipated to constitute a large market share during the projected period due to the increase in number of at-home screening of cervical cancer. On the other hand, the consumables segment is anticipated to expand at a robust growth rate during the forecast period owing to growing activities by key market players through the launch of novel consumables such as assays and kits for more precise HPV and Pap tests.
North America is anticipated to constitute a key market share
In terms of regions, the global HPV testing and Pap test market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key share of the market during the targeted period owing to increased awareness about early diagnosis of cervical cancer and healthcare remuneration scenarios in the region. On the other hand, the market of Asia Pacific is anticipated to expand at a healthy growth rate during the forecast period due to rising number of cancers and increasing adoption of advanced technology in the region.
Competitive Landscape
Key players competing in the HPV testing and Pap test market are Abbott Laboratories; Qiagen N.V.; Becton, Dickinson and Company; Quest Diagnostics, Inc.; Hologic, Inc.; F. Hoffmann-La Roche AG; Femasys, Inc.; Arbor Vita Corporation; NURX, Inc.; Seegene, Inc.; Thermo Fisher Scientific, Inc.; and bioMérieux SA. Qiagen N.V. developed the QIAscreen HPV PCR Test, in November 2018, which was a molecular diagnostic test used to diagnose HPV.
About Growth Market Reports:
GROWTH MARKET REPORTS provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. GROWTH MARKET REPORTS has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys.
Contact:
Growth Market Reports
Phone: +1 909 414 1393
Email: [email protected]
Web: https://growthmarketreports.com
According to the new market research report “HPV Testing & Pap Test Market by Test Type (HPV Testing (Follow-Up, Co-Testing, Primary)), by Application (Pap Test (Cervical Cancer, Vaginal Cancer)), by End-User (Laboratories, Hospitals, Physicians’ Offices & Clinics) — Global Forecast to ”, published by MarketsandMarkets™, provides a detailed overview of the major drivers, restraints, opportunities, challenges, current market trends, and strategies impacting the market along with estimates and forecasts of revenue.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=214207371A number of factors such as increasing number of cervical cancer cases, growing aging population, increasing awareness of cervical cancer screening programs, and government initiative and funding are propelling the growth of the HPV testing and Pap test market.Browse and in-depth TOC on “ HPV Testing and Pap Test Market “80 - Tables52 - Figures124 - PagesHPV testing and Pap test market has been divided into two major segments on basis of test type, namely, HPV testing and Pap test.
Follow-up HPV testing, co-testing, HPV primary testing are three sub-segments of HPV testing.
The Pap test segment is expected to account for the largest share of the HPV testing and Pap test market in 2015.
HPV testing segment is expecHPV Testing and Pap Testted to grow at the highest CAGR in the next five years.
This fastest growth is attributed to the increasing incidences of cervical cancer, raising awareness of HPV screening, as well as the introduction of HPV primary test.Request for Free Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=214207371HPV testing and Pap test market is classified into three segments on the basis of end users, namely, hospitals, laboratories, physicians’ offices and clinics.
The laboratories end-user segment is expected account for the largest share of the HPV testing and Pap test market in 2015.
The Global HPV Testing and Pap Test Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.The report offers a value chain analysis that gives a comprehensive outlook of the HPV testing and Pap test market.
The attractiveness analysis of this market has also been included so as to evaluate the segments that are anticipated to be profitable during the forecast period.Browse the complete Global HPV Testing And Pap Test Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 @ https://www.decisiondatabases.com/ip/6817-hpv-testing-and-pap-test-market-reportThe report also covers the complete competitive landscape of the global HPV Testing And Pap Test market with company profiles of key players such as:Abbott LaboratoriesQiagen N.V.Roche DiagnosticsHologic, Inc.Becton, Dickinson and CompanyQuest DiagnosticsOnco Health CorporationSeegene, Inc.Femasys Inc.Arbor Vita CorporationSEGMENTATIONS IN REPORT:HPV Testing And Pap Test Market Analysis By Type:HPV TestingFollow-Up HPV TestingCo-TestingHPV Primary TestingPap TestHPV Testing And Pap Test Market Analysis By Applications:Pap TestCervical Cancer ScreeningVaginal Cancer ScreeningHPV Testing And Pap Test Market Analysis By End User:LaboratoriesHospitalsPhysician’s Offices & ClinicsHPV Testing And Pap Test Market Analysis By Geography:North AmericaEuropeAsia PacificRest of the WorldDownload Free Sample Report of Global HPV Testing And Pap Test Market @ https://www.decisiondatabases.com/contact/download-sample-6817The Global HPV Testing And Pap Test Market has been exhibited in detail in the following chapters –Chapter 1 HPV Testing And Pap Test Market PrefaceChapter 2 Executive SummaryChapter 3 HPV Testing And Pap Test Industry AnalysisChapter 4 HPV Testing And Pap Test Market Value Chain AnalysisChapter 5 HPV Testing And Pap Test Market Analysis By TypeChapter 6 HPV Testing And Pap Test Market Analysis By ApplicationsChapter 7 HPV Testing And Pap Test Market Analysis By End UserChapter 8 HPV Testing And Pap Test Market Analysis By GeographyChapter 9 Competitive Landscape Of HPV Testing And Pap Test CompaniesChapter 10 Company Profiles Of HPV Testing And Pap Test IndustryPurchase the complete Global HPV Testing And Pap Test Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-6817Other Reports by DecisionDatabases.com:Global Sterility Testing Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global In-Vitro Toxicology Testing Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026Global Healthcare Analytical Testing Services Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
Global HPV Testing & Pap Test Market, By Test Type ((HPV Testing), Follow-Up HPV Testing, Co-Testing, Primary HPV Testing, PAP Test)), Application (Cervical Cancer Screening, Vaginal Cancer Screening), End Users (Laboratories, Hospitals, Physicians’ Offices Clinics), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025The Global HPV Testing & PAP Test Market is expected to reach USD 5840.7 million by 2025, growing at a CAGR of 6.6% during the forecast period of 2018 to 2025.
Irregular findings are usually followed up by more sensitive diagnostic tests and based on the need interventions that prevent progression to cervical cancer are implemented.
All such cancers originate from Human Papillomavirus (HPV) infection.
Various developments are made by the key players for the improvement of this test In April 2018, QIAGEN N.V. launched two novel liquid biopsy panels to evaluate circulating tumor cells (CTCs) in the growing field of research into molecular mechanisms in prostate and lung cancers.
The AdnaTest ProstateCancerPanel AR-V7 Kit and AdnaTest LungCancer Kit will be introduced at the American Association for Cancer Research (AACR) 2018.
Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others.Some of the major players operating in the global HPV testing & PAP test market are Abbott Laboratories, Qiagen N.V., Roche Diagnostics, Hologic, Inc., Becton, Dickinson and Company, Quest Diagnostics, Onco Health Corporation, Seegene, Inc., Femasys Inc., Arbor Vita Corporation, QiagenN.
Several recent research have shed some much-needed light on the HPV and PAP testing controversy.
The research examined the risk variables for HPV and PAP tests and discovered that there was no significant difference in HPV or PAP infections when co-infected.HPV and PAP testing were first suggested as a regular way of HPV testing for patients who had no signs of cervical cancer.
Normal HPV and PAP testing procedures were previously employed to identify HPV infections, but they failed to discover any abnormalities.
The issue is that many patients with normal pap smears may still contain the HPV infection.
As a result, HPV and PAP testing became an important component of HPV immunology.
This test would assist determine whether the patient still contains the virus, but it would also help screen others who could be carriers, lowering the risk of cervical cancer.The researchers discovered that women with normal pap smears did not require HPV and PAP tests as frequently as those with abnormal pap smears.
